MICEK JOHN 4

What Happened
John Micek, a director of Jaguar Health, received two compensation awards on December 11, 2025: 7,377 restricted stock units (RSUs) and 7,377 derivative option-type awards. Both grants are shown at $0.00 on the Form 4 (typical for equity awards); no cash purchase or sale occurred. The RSUs convert to common shares upon vesting; the options are derivative awards that vest over time per the grant terms.

Key Details

• Transaction date: December 11, 2025; Form 4 filed March 12, 2026 (filing appears late relative to the transaction).
• Awards: 7,377 RSUs (non‑cash award) and 7,377 derivative/option awards, reported as acquisitions at $0.00.
• Vesting: RSUs vest on December 11, 2026 (one-year cliff per filing). Options vest ratably monthly over 12 months from grant date, contingent on continued service.
• Plan/approval: Grants made under the issuer’s 2014 Stock Incentive Plan and approved by the board on Dec 11, 2025.
• Shares owned after transaction: Not specified in the filing.
• Other notes: Filing includes prior reverse stock splits (60-for-1 in May 2024 and 25-for-1 in Mar 2025) that affect historical share counts.

Context
These are compensatory equity awards to a director (not open‑market purchases or insider sales). RSUs convert to shares only when they vest; options are derivative awards that vest over time and are not the same as an immediate exercised sale. The late filing notifies the market of the grants but may reflect an administrative delay rather than substantive trading activity.